Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Coherus BioSciences Inc. (CHRS)

20.36   0 (0%) 05-24 16:00
Open: 20.58 Pre. Close: 20.36
High: 20.6 Low: 19.8
Volume: 883,381 Market Cap: 1412M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.623 - 20.705 20.705 - 20.776
Low: 19.578 - 19.677 19.677 - 19.762
Close: 20.186 - 20.35 20.35 - 20.492

Technical analysis

as of: 2019-05-26 10:09:46 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 24.74     One year: 28.89
Support: Support1: 16.46    Support2: 13.55
Resistance: Resistance1: 21.18    Resistance2: 24.74
Pivot: 17.96
Moving Average: MA(5): 20.02     MA(20): 17.48
MA(100): 14.40     MA(250): 14.64
MACD: MACD(12,26): 1.34     Signal(9):
Stochastic oscillator: %K(14,3): 87.12     %D(3): 89.84
RSI: RSI(14): 77.81
52-week: High: 21.18  Low: 8.32  Change(%): 33.1
Average Vol(K): 3-Month: 89176  10-Days: 107551

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CHRS has closed below upper band by 12.9%. Bollinger Bands are 119.1% wider than normal. The large width of the bands suggest high volatility as compared to CHRS's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Thu, 23 May 2019 17:12:48 Z
Amgen (AMGN) Offers to Acquire Drug Discovery Platform

Fri, 10 May 2019 01:58:12 Z
Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript

Thu, 09 May 2019 23:58:37 Z
Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates

Fri, 26 Apr 2019 13:22:34 Z
Moving Average Crossover Alert: Coherus BioSciences

Thu, 25 Apr 2019 15:19:52 Z
The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 69.37
Shares Float (M) 69.01
% Held by Insiders 0.60
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -3.210
EPS Est. Current Year -5.130
EPS Est. Next Year -2.620
EPS Est. Next Quarter -0.760
Forward EPS -1.421
Book Value (p.s.) 74.180
PEG Ratio -0.71
Profit Margin
Operating Margin -472.05
Return on Assets (ttm) -117.7
Return on Equity (ttm) 918.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -182.66
Levered Free Cash Flow (M) -111.43

Stock Valuations

P/E -6.34
P/E Growth Ratio
P/BV 0.27
P/S 2567951360.00
P/CF -7.73

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.